I am Managing Director of the the Medicines Manufacturing Innovation Centre at CPI. The centre is a collaboration between CPI, University of Strathclyde, Innovate UK, Scottish Enterprise and founding industry partners, AstraZeneca and GSK. Prior to joining CPI I worked for GSK, I joined the company in 1992 as a PhD Chemist from Glasgow University. I have over 20 years’ experience at GSK carrying out a number of Technical, Compliance and Manufacturing leadership roles. In 1997 I moved to Irvine to take up a lead chemist role before coming Quality Control Manager in 1998. I joined the site leadership team in 2001 to run Technical Development before moving to manufacturing as Actives Production Director in 2005.During this time, I completed a Masters degree in Manufacturing Leadership at Cambridge University. In 2007 I moved to GSK House to work on a central network re-structuring project before becoming Site Director at Montrose in October 2008. At Montrose, I led the transformation of the site to manufacture over 12 products for GSK including a major investment programme. In 2011 I was appointed VP Primary Supply Chain with responsibility for global Active Pharmaceutical Ingredients (API) manufacture and supply, a network of GMS sites across the world including facilities in Asia and Europe. In 2017 I was appointed VP Head of GMS Strategy with responsibility for manufacturing strategy, deployment of strategic programmes, performance management and advocacy.I play an active role with a number of Governments and am currently co-chair of the Life Sciences Scotland Industry Leadership Group.